Adrenal insufficiency induced by immune checkpoint inhibitors anticancer therapy

Adrenal insufficiency induced by immune checkpoint inhibitors anticancer therapy

Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment and significantly improved the prognosisof patients with advanced tumors. The ICIs are monoclonal antibodies that inhibit regulatory proteins, namely cytotoxicT-lymphocyte-associated antigen 4 (CTLA-4), programmed cell death 1...

Full description

Saved in:

Bibliographic Details
Main Authors:	Paulina Ramaneckaite, Zuzanna Ratuszna, Julia Brymora, Ewa Zalewska, Renata Stodulska-Świątkowska
Format:	Article
Language:	English
Published:	Via Medica 2025-01-01
Series:	Nowotwory
Subjects:	adrenal cortex insufficiency immune-related adverse events anticancer drugs immune checkpoint inhibitors ACTH deficiency
Online Access:	https://journals.viamedica.pl/nowotwory_journal_of_oncology/article/view/104812
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Retrospective analysis of clinical characteristics and treatment of patients with immune checkpoint inhibitors-induced adrenal insufficiency
by: Xiao Huang, et al.
Published: (2025-08-01)

Redefining the Diagnostic Approach to Adrenal Insufficiency: Re-Assessment of Baseline and Cortisol Increment Cut-Offs with the 1 µg Synacthen Test
by: Taieb Ach, et al.
Published: (2025-07-01)

Endocrine adverse events of immune checkpoint inhibitors: results of a single-center study
by: E. V. Poddubskaya, et al.
Published: (2019-12-01)

Arterial stiffness and shortened QTc interval are associated with androgen and ACTH levels in classic congenital adrenal hyperplasia
by: Lorenzo Campioni, et al.
Published: (2025-08-01)

The Effectiveness of Acth Therapy According to Etiology in Patients with West Syndrome and Its Long-Term Effects on Bone Mineral Metabolism and Adrenal Pathway
by: Mesut Güngör, et al.
Published: (2022-05-01)

Congenital Adrenal Hyperplasia and Adrenal Insufficiency in Children: An Evidence-based Review with Good Practice Points by Adrenal Working Group of The Turkish Society for Pediatric Endocrinology and Diabetes
by: Zeynep Şıklar
Published: (2025-01-01)

ACTH more than 2000 pg/ml; is it immunoassay interference or another matter?
by: Vivek Pant, et al.
Published: (2023-07-01)

Association of polymorphic markers in innate immunity receptor genes with the risk of primary adrenal insufficiency
by: N. D. Rasskazova, et al.
Published: (2025-06-01)

Sudden cardiac death due to adrenal insufficiency masquerading as Brugada syndrome. Case report
by: N. V. Kijvatova, et al.
Published: (2024-10-01)

Bilateral Adrenal Ablation for the Treatment of Ectopic ACTH Syndrome With Severe Hypokalemia: A Case Report and a Literature Review
by: Fang Sun, et al.
Published: (2025-08-01)

Adrenal Disorders in Pregnancy. A Comprehensive Review and Prospects for Future Research
by: Kinga Filipek, et al.
Published: (2024-11-01)

A case of adrenal insufficiency presenting with seizures, complicated by developmental cerebral venous anomaly and Takotsubo cardiomyopathy: a case report
by: Katrina Villegas, et al.
Published: (2025-08-01)

Anticancer drug therapy for anaplastic thyroid cancer
by: Naomi Kiyota, et al.
Published: (2025-04-01)

Case Report: Bilateral adrenal hemorrhage in a patient with systemic lupus erythematosus and antiphospholipid syndrome
by: Yuwei Wang, et al.
Published: (2025-08-01)

Adverse reactions of immune checkpoint inhibitors
by: E. R. Zagidullina, et al.
Published: (2025-06-01)

Chronic adrenal insufficiency in children and adolescents (part 1)
by: V. V. Smirnov, et al.
Published: (2021-06-01)

Clinical characteristic analysis of immune checkpoint inhibitor-related pituitary adverse events
by: Yufan ZHENG, et al.
Published: (2025-08-01)

Analysis of the clinical characteristics of immune checkpoint inhibitor-related hypophysitis
by: Zhixiao WANG, et al.
Published: (2025-08-01)

Clinical characteristics and comparative analysis of PD-1/PD-L1 inhibitor-induced pituitary dysfunction versus other pituitary disorders
by: Yan Xiao, et al.
Published: (2025-07-01)

The distinct landscape of tumor immune microenvironment in homologous recombination deficient cancers
by: Qiuyang Xu, et al.
Published: (2025-08-01)

Arthropathy associated with antitumor checkpoint inhibitors therapy: current understanding of the problem
by: A. D. Koltakova, et al.
Published: (2023-10-01)

Differential distribution of immune checkpoints across molecular subtypes of colorectal cancer
by: Sofia Edin, et al.
Published: (2025-12-01)

Immune Checkpoint Inhibitor‐Related Dysautonomia in Merkel Cell Carcinoma: A Case Report
by: Nidhi Kuchimanchi, et al.
Published: (2025-07-01)

Clinical, Biochemical and Molecular Characteristics of Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency
by: Sevinç Odabaşı Güneş, et al.
Published: (2025-01-01)

Efgartigimod therapy for immune checkpoint inhibitor–associated myasthenia gravis with myositis: a case report
by: Feiteng Qi, et al.
Published: (2025-07-01)

Immune-checkpoint inhibitor resistance in patients with cancer
by: Luis Cabezón-Gutiérrez, et al.
Published: (2025-05-01)

Prognostic impact of biomarkers in PMBCL: rationale for early integration of immune checkpoint inhibitors
by: Yana K. Mangasarova, et al.
Published: (2025-05-01)

Expression of immune checkpoint markers in peripheral blood lymphocytes of women with fibroadenoma of the breast
by: O. V. Kurmyshkina, et al.
Published: (2024-09-01)

Off-Label Drug Use in Oncology
by: E. V. Karabina, et al.
Published: (2022-07-01)

Neurotransmitters: an emerging target for therapeutic resistance to tumor immune checkpoint inhibitors
by: Jiyuan Yang, et al.
Published: (2025-08-01)

Stereotactic body radiation therapy or conventional fractionated radiotherapy combined with immune checkpoint inhibitors? From biological perspectives
by: Yanmei Liu, et al.
Published: (2025-08-01)

Function of 18F-FDG PET/CT radiomics in the detection of checkpoint inhibitor-induced liver injury (CHILI)
by: Clémence M. C. Huigen, et al.
Published: (2025-08-01)

Immune Signatures of Solid Tumor Patients Treated With Immune Checkpoint Inhibitors: An Observational Study
by: Ling Chen, et al.
Published: (2025-01-01)

The anticancer thiosemicarbazone triapine exerts immune-enhancing activities via immunogenic cell death induction and FAS upregulation
by: Bianca Stiller, et al.
Published: (2025-08-01)

Concomitant anticoagulants and the survival of cancer patients treated with immune checkpoint inhibitors: a meta-analysis
by: Jin Xiong, et al.
Published: (2025-08-01)

Development and validation of a multidisciplinary risk assessment scale for immune checkpoint inhibitor-associated myocarditis
by: Yanan DAI, et al.
Published: (2025-08-01)

Pathogenesis, diagnosis and treatment of immune checkpoint inhibitor related bullous pemphigoid
by: Yi SUN, et al.
Published: (2025-04-01)

Immune checkpoint inhibitor-related myocarditis during DUO-E regimen for endometrial cancer: The first case report in gynecologic oncology
by: Eri Yamabe, et al.
Published: (2025-10-01)

Metabolic checkpoints in immune cell reprogramming: rewiring immunometabolism for cancer therapy
by: Yingying Lv, et al.
Published: (2025-08-01)

SIRPA, BTN3A1, and TDO2 in osteosarcoma: a prognostic triad with therapeutic implications from integrated genomic and pharmacogenomic data
by: Han-jing Zhang, et al.
Published: (2025-08-01)